The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
The role of STATs in transcriptional control and their impact on cellular function
Abstract
The STAT proteins (Signal Transducers and Activators of Transcription), were identified in the last decade as transcription factors which were critical in mediating virtually all cytokine driven signaling. These proteins are latent in the cytoplasm and become activated through tyrosine phosphorylation which typically occurs through cytokine receptor associated kinases (JAKs) or growth factor receptor tyrosine kinases. Recently a number of non-receptor tyrosine kinases (for example src and abl) have been found to cause STAT phosphorylation. Phosphorylated STATs form homo- or hetero-dimers, enter the nucleus and working coordinately with other transcriptional co-activators or transcription factors lead to increased transcriptional initiation. In normal cells and in animals, ligand dependent activation of the STATs is a transient process, lasting for several minutes to several hours. In contrast, in many cancerous cell lines and tumors, where growth factor dysregulation is frequently at the heart of cellular transformation, the STAT proteins (in particular Stats 1, 3 and 5) are persistently tyrosine phosphorylated or activated. The importance of STAT activation to growth control in experiments using anti-sense molecules or dominant negative STAT protein encoding constructs performed in cell lines or studies in animals lacking specific STATs strongly indicate that STATs play an important role in controlling cell cycle progression and apoptosis. Stat1 plays an important role in growth arrest, in promoting apoptosis and is implicated as a tumor suppressor; while Stats 3 and 5 are involved in promoting cell cycle progression and cellular transformation and preventing apoptosis. Many questions remain including: (1) a better understanding of how the STAT proteins through association with other factors increase transcription initiation; (2) a more complete definition of the sets of genes which are activated by different STATs and (3) how these sets of activated genes differ as a function of cell type. Finally, in the context of many cancers, where STATs are frequently persistently activated, an understanding of the mechanisms leading to their constitutive activation and defining the potential importance of persistent STAT activation in human tumorigenesis remains. Oncogene (2000).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-6 is also a key factor in inflammation, autoimmunity and cancer, with its effect mainly exerted through the IL-6–signal transducer and activator of transcription 3 (STAT3) pathway (18–26, 61–65).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [61]
In the citing paper
“HCV core protein interacts with the signal transducer and activator of transcription 3 (STAT3) protein36, a transcription factor involved in mediating cytokine signalling37.”
From Inflammation and cancer (2002) · cites this paper as [37]
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Darnell, J. E. (1997) · Science · doi:10.1126/science.277.5332.1630 · Cited by 3,979
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
Self-citationWen, Z., Zhong, Z., & Darnell, J. E. (1995) · Cell · doi:10.1016/0092-8674(95)90311-9 · Cited by 1,974
Meraz, M. A., White, J. M., Sheehan, K. C. F., Bach, E. A., Rodig, S. J., Dighe, A. S., Kaplan, D. H., Riley, J. K., Greenlund, A. C., Campbell, D., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81288-x · Cited by 1,656
Targeted Disruption of the Mouse Stat1 Gene Results in Compromised Innate Immunity to Viral Disease
Durbin, J. E., Hackenmiller, R., Simon, M. C., & Levy, D. E. (1996) · Cell · doi:10.1016/s0092-8674(00)81289-1 · Cited by 1,539
A Matter of Life and Cell Death
Evan, G. I., & Littlewood, T. D. (1998) · Science · doi:10.1126/science.281.5381.1317 · Cited by 1,528
Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice
Kaplan, D. H., Shankaran, V., Dighe, A. S., Stockert, E., Aguet, M., Old, L. J., & Schreiber, R. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7556 · Cited by 1,465
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,000
Pan, L., Chen, X. '., Rassool, F. V., Li, C., & Lin, J. (2022) · Biomedicines · doi:10.3390/biomedicines10082003 · Cited by 18
SHORT COMMUNICATION: STAT3 Polymorphisms Linked with Idiopathic Recurrent Miscarriages
Finan, R. R., Mustafa, F. E., Al-Zaman, I., Madan, S., Issa, A. A., & Almawi, W. Y. (2009) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2009.00765.x · Cited by 18
Jeon, Y. J., Jung, S., Chang, H., Yun, J., Lee, C. W., Lee, J., Choi, S., Nash, O., Han, D. C., & Kwon, B. (2015) · Phytotherapy Research · doi:10.1002/ptr.5311 · Cited by 19
Tumor-Induced Immune Suppression
Gabrilovich, D. I., & Hurwitz, A. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-69118-3 · Cited by 18
Hbibi, A. T., Laguillier, C., Souissi, I., Lesage, D., Coquil, S. L., Cao, A., Metelev, V., Baran‐Marszak, F., & Fagard, R. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.06975.x · Cited by 18
Diverse effects of Stat1 on the regulation of hsp90α gene under heat shock
Chen, X., Zhang, Y., Wang, J., Li, X., Cheng, X.-K., Zhang, Y., Wu, N., & Shen, Y. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21342 · Cited by 18
Lu, J., Power, C., Blevins, G., Giuliani, F., & Yong, V. W. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000011 · Cited by 18
Ohta, K., Naruse, T., Kato, H., Ishida, Y., Nakagawa, T., Ono, S., Shigeishi, H., & Takechi, M. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.7432 · Cited by 18
Tsurumi, A., Zhao, C., & Li, W. X. (2017) · BMC Genomics · doi:10.1186/s12864-017-4058-y · Cited by 18
Resistance to fludarabine-induced apoptosis in Epstein-Barr virus infected B cells
Fagard, R., Mouas, H., Dusanter‐Fourt, I., Devillers, C., Bissières, P., Martin, A., Lenoir, G., Tan, H. V., Feuillard, J., & Raphaël, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205554 · Cited by 18
Araki, T., Kawata, T., & Williams, J. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202715109 · Cited by 17
Isolation and Characterization of the Rat SND p102 Gene Promoter
Rodríguez, L., Bartolomé, N., Ochoa, B., & Martínez, M. J. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1378.074 · Cited by 17
Interleukin-6 promotes microtubule stability in axons via Stat3 protein–protein interactions
Wareham, L. K., Echevarría, F. D., Sousa, J. L., Konlian, D. O., Dallas, G., Formichella, C. R., Sankaran, P., Goralski, P. J., Gustafson, J. R., & Sappington, R. M. (2021) · iScience · doi:10.1016/j.isci.2021.103141 · Cited by 17
Design, synthesis and evaluation of XZH-5 analogues as STAT3 inhibitors
Daka, P., Liu, A., Karunaratne, C. V., Csatary, E. E., Williams, C., Xiao, H., Lin, J., Xu, Z., Page, R. C., & Wang, H. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.01.025 · Cited by 17
Gupta, R., Li, W., Yan, X., Barrientos, J. C., Kolitz, J. E., Allen, S. L., Rai, K. R., Chiorazzi, N., & Mongini, P. K. A. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801142 · Cited by 17
Nair, V. S., Saleh, R., Toor, S. M., Alajez, N. M., & Elkord, E. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01530 · Cited by 18
Safari, F., Nejad, N. S., & Nejad, A. A. (2022) · Medical Oncology · doi:10.1007/s12032-022-01649-4 · Cited by 17
Zhu, R., Xu, R., Jiang, X., Cai, Y., Zou, Y., Du, M.-X., & Qin, L. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21426 · Cited by 17
STAT 3 activation in head and neck squamous cell carcinomas is controlled by the EGFR.
Hambek, M., Baghi, M., Strebhardt, K., Strebhard, K., May, A., Adunka, O. F., Gstöttner, W., & Knecht, R. (2004) · PubMed · Cited by 17
Li, N., Ou, J., Bao, N., Cheng, C., Shi, Z., Chen, L., & Sun, J. (2020) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2020.104208 · Cited by 17
Ebong, S., Chepelinsky, A. B., Robinson, M. L., Zhao, H., Yu, C., & Egwuagu, C. E. (2004) · PubMed · Cited by 17
Li, X., Zhang, F., Qu, L., Xie, Y., Ruan, Y., Guo, Z., Mao, Y., Zou, Q., Shi, M., Xiao, Y., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30415 · Cited by 17
Updates in pathobiological aspects of anaplastic large cell lymphoma
Wu, R., & Lim, M. S. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1241532 · Cited by 16
Dhar, S., Chakravarti, M., Ganguly, N., Saha, A., Dasgupta, S., Bera, S., Sarkar, A., Roy, K., Das, J., Bhuniya, A., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1303959 · Cited by 16
Revealing the cellular localization of STAT1 during the cell cycle by super-resolution imaging
Gao, J., Wang, F., Liu, Y., Cai, M., Xu, H., Jiang, J., & Wang, H. (2015) · Scientific Reports · doi:10.1038/srep09045 · Cited by 16
CHO, S.-D., Yu, H., Park, C., Kim, S., & Cho, N. (2014) · Pharmacognosy Magazine · doi:10.4103/0973-1296.139802 · Cited by 16
Analysis of differentially expressed genes based on microarray data of glioma.
Jiang, C., Wang, X., Shu, J., Yang, W., Fu, P., Zhuang, L.-L., & Zhou, G. (2015) · PubMed Central · Cited by 16
Chen, S., Yang, C., Zhang, W., Mahalingam, S., Wang, M., & Cheng, A. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.05.004 · Cited by 16
Li, L., Shen, A., Chu, J., Sferra, T. J., Sankararaman, S., Ke, X., Chen, Y., & Peng, J. (2018) · Molecular Medicine Reports · doi:10.3892/mmr.2018.9051 · Cited by 16
Zhang, L., Peterson, T. E., Lu, V. M., Parney, I. F., & Daniels, D. J. (2019) · PLoS ONE · doi:10.1371/journal.pone.0220569 · Cited by 16
ARL3, a small GTPase with a functionally conserved role in primary cilia and immune synapses
Powell, L., Samarakoon, Y., Ismail, S., & Sayer, J. A. (2019) · Small GTPases · doi:10.1080/21541248.2019.1703466 · Cited by 17
Sivák, L., Šubr, V., Kovářová, J., Dvořáková, B., Šírová, M., Řı́hová, B., Randárová, E., Kraus, M., Tomala, J., Studenovský, M., et al. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.015 · Cited by 16
Tyrphostin AG-490 inhibited the acute phase of zymosan-induced inflammation
Dimitrova, P. A., & Ivanovska, N. (2008) · International Immunopharmacology · doi:10.1016/j.intimp.2008.06.013 · Cited by 16
Zhang, Y. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.801 · Cited by 16
Dual regulation of a Dictyostelium STAT by cGMP and Ca2+ signalling
Araki, T., van Egmond, W. N., Haastert, P. J. M. V., & Williams, J. G. (2010) · Journal of Cell Science · doi:10.1242/jcs.064436 · Cited by 16
Ha- ras Oncogene–Induced Stat3 Phosphorylation Enhances Oncogenicity of the Cell
Yeh, H.-H., Raghavaraju, G., Chang, T., Chou, C.-Y., Su, W., & Liu, H. (2009) · DNA and Cell Biology · doi:10.1089/dna.2008.0762 · Cited by 16
IGF‐1 stimulated upregulation of cyclin D1 is mediated via STAT5 signaling pathway in neuronal cells
Kalita, A., Gupta, S., Singh, P., Surolia, A., & Banerjee, K. (2013) · IUBMB Life · doi:10.1002/iub.1152 · Cited by 16
Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase proteinin vivo
Gabay, C., Gigley, J. P., Sipe, J. D., Arend, W. P., & Fantuzzi, G. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(200102)31:2 · Cited by 61
Molecular biology in head and neck cancer
Hitt, R., & Echarri, M. J. (2006) · Clinical & Translational Oncology · doi:10.1007/s12094-006-0131-8 · Cited by 16
Bazedoxifene as a Potential Cancer Therapeutic Agent Targeting IL-6/GP130 Signaling
Shi, C., Bopp, T. S., Lo, H., Tkaczuk, K. H. R., & Lin, J. (2024) · Current Oncology · doi:10.3390/curroncol31100426 · Cited by 15
Najjar, I., Schischmanoff, P. O., Baran‐Marszak, F., Deglesne, P., Youlyouz‐Marfak, I., Pampin, M., Feuillard, J., Bornkamm, G. W., Chelbi‐Alix, M. K., & Fagard, R. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.0508287 · Cited by 15
A New STAT3-binding Partner, ARL3, Enhances the Phosphorylation and Nuclear Accumulation of STAT3
Togi, S., Muromoto, R., Hirashima, K., Kitai, Y., Okayama, T., Ikeda, O., Matsumoto, N., Kon, S., Sekine, Y., Oritani, K., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.724849 · Cited by 16
Chronic Inflammation and Carcinogenesis – Emerging Role of Chronic Inflammatory Periodontal Disease
Grover, V., Kapoor, A., Sehgal, K., & Kaur, G. (2016) · Cancer Research Frontiers · doi:10.17980/2016.200 · Cited by 15
Identification of KPNB1 as a Cellular Target of Aminothiazole Derivatives with Anticancer Activity
Kim, Y., Ha, S., Kim, J., & Ham, S. W. (2016) · ChemMedChem · doi:10.1002/cmdc.201600159 · Cited by 15
Chen, H., Shen, A., Liu, L., Peng, J., & Chu, J. (2019) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-019-3010-1 · Cited by 15
The Therapeutic Potential of Resveratrol in Gliomas
Richard, S. A. (2019) · Advances in Bioscience and Clinical Medicine · doi:10.7575/aiac.abcmed.v.7n.2p.44 · Cited by 15
Fu, Y., Zhu, F., Ma, Z., Lü, B., Wang, X., Dai, C., Ma, X., Liu, P., Lv, H., Chen, X., et al. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s282334 · Cited by 15
Monahan, A., & Starz‐Gaiano, M. (2015) · Mechanisms of Development · doi:10.1016/j.mod.2015.08.003 · Cited by 17
The role of signal transducer and activator of transcription 3 in Rift Valley fever virus infection
Pinkham, C., An, S., Lundberg, L., Bansal, N., Benedict, A., Narayanan, A., & Kehn‐Hall, K. (2016) · Virology · doi:10.1016/j.virol.2016.06.004 · Cited by 17
Hornig, J., Choi, K. Y., & McGregor, A. (2017) · Virology · doi:10.1016/j.virol.2017.01.023 · Cited by 15
Ruggieri, S., Tamma, R., Resta, N., Albano, F., Coccaro, N., Loconte, D. C., Annese, T., Errede, M., Specchia, G., Senetta, R., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.16115 · Cited by 15
Wang, W., Diao, Y., Li, W., Luo, Y., Yang, T., Zhao, Y., Qi, T., Xu, F., Ma, X., Ge, H., et al. (2019) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2019.04.011 · Cited by 15
Li, X., Na, H., Xu, L., Zhang, X., Feng, Z., Zhou, X., Cui, J., Zhang, J., Lin, F., Yang, S., et al. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109644 · Cited by 15
Yu, L.-F. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i6.875 · Cited by 15
Targeting proliferation and survival pathways in head and neck cancer for therapeutic benefit
Johnson, D. E. (2012) · 癌症:英文版 · doi:10.5732/cjc.011.10404 · Cited by 15
Natural bioactive compounds and STAT3 against hepatocellular carcinoma: An update
Manoharan, S., Saha, S., Murugesan, K., Santhakumar, A., & Perumal, E. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122351 · Cited by 14
Teng, C., Chen, J., Shen, L., Chen, S., & Chen, G. (2025) · Cancer Drug Resistance · doi:10.20517/cdr.2024.178 · Cited by 14
Heart Peptide Hormones: Adjunct and Primary Treatments of Cancer
Vesely, D. L. (2016) · Anticancer Research · doi:10.21873/anticanres.11152 · Cited by 14
Gabriele, E., Brambilla, D., Ricci, C., Regazzoni, L., Taguchi, K., Ferri, N., Asai, A., & Sparatore, A. (2017) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2017.1350658 · Cited by 14
Liu, Y., Wang, Y., Zhang, M.-D., Yue, W., & Sun, C.-N. (2020) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2020.104521 · Cited by 14
Expression of STAT5, COX-2 and PIAS3 in Correlation with NSCLC Histhopathological Features
Pastuszak‐Lewandoska, D., Domańska, D., Czarnecka, K. H., Kordiak, J., Migdalska‐Sęk, M., Nawrot, E., Kiszałkiewicz, J., Antczak, A. J., Górski, P., & Brzeziańska‐Lasota, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104265 · Cited by 14
Kachroo, M. H. L. P. (2014) · Journal of Cancer Science & Therapy · doi:10.4172/1948-5956.1000310 · Cited by 14
Singh, N., Hussain, S., Bharadwaj, M., Kakkar, N., Singh, S. K., & Sobti, R. C. (2012) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2012.733885 · Cited by 15
Ando, T., Kudo, Y., Iizuka, S., Tsunematsu, T., Umehara, H., Shrestha, M., Matsuo, T., Kubo, T., Shimose, S., Arihiro, K., et al. (2017) · Scientific Reports · doi:10.1038/srep40187 · Cited by 14
Liang, N., Li, S., Liang, Y., Ma, Y., Tang, S., Ye, S., & Xiao, F. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112447 · Cited by 14
Huda, K. A. S. M., Guo, L., Haga, S., Murata, H., Ogino, T., Fukai, M., Yagi, T., Iwagaki, H., Tanaka, N., & Ozaki, M. (2006) · Transplant International · doi:10.1111/j.1432-2277.2006.00285.x · Cited by 14
Kim, Y., Kwon, E.-K., Jeon, J., So, I., Kim, I.-G., Choi, M., Kim, I.-S., Choi, J.-K., Jung, J. U., & Cho, N. (2011) · Journal of General Virology · doi:10.1099/vir.0.036087-0 · Cited by 14
Siavash, H., Nikitakis, N. G., & Sauk, J. J. (2004) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130401500505 · Cited by 14
Immunobiology of hepatocarcinogenesis: Ways to go or almost there?
Patel, P., Schutzer, S. E., & Pyrsopoulos, N. (2016) · World Journal of Gastrointestinal Pathophysiology · doi:10.4291/wjgp.v7.i3.242 · Cited by 16
Hbibi, A. T., Lagorce, C., Wind, P., Spano, J., Guetz, G. D., Milano, G. A., Benamouzig, R., Rixe, O., Morère, J., Breau, J. L., et al. (2008) · Cancer Biomarkers · doi:10.3233/cbm-2008-4204 · Cited by 15
Hsu, C., Yang, W.-T., Lin, J., Lu, C., Hu, K.-C., Lan, T., & Chang, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411852 · Cited by 13
Lee, K., Choi, Y., Lim, H.-I., Cho, K.-J., Kang, N., & Ko, S. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-024-04347-y · Cited by 13
Han, T., Xu, Y., Liu, H., Sun, L., Cheng, X., Shen, Y., & Wei, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094920 · Cited by 14
Xiao, J., Wang, J., Li, J., Xiao, J., Liu, C., Tan, L., Tu, Y., Yang, R., Pei, Y., Wong, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-024-55617-9 · Cited by 14
Family of peptides synthesized in the human body have anticancer effects.
Vesely, D. L. (2014) · PubMed · Cited by 13
Wu, Y., Wan, X., Zhao, X., Song, Z., Xu, Z., Tao, Y., & Sun, C. (2020) · PubMed Central · Cited by 13
RetractedOzenne, P., Daydé, D., Brambilla, E. M., Eymin, B., & Gazzéri, S. (2012) · Oncogene · doi:10.1038/onc.2012.107 · Cited by 16
Liu, X., Zhang, L., Wang, X., Li, S.-C., Hu, Y., Zhang, J., Xian, X., Li, W., & Zhang, M. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03703-2 · Cited by 13
The Role of Interleukin-1 Receptor-Associated Kinases in Vogt-Koyanagi-Harada Disease
Sun, M., Yang, P., Du, L., Yang, Y., & Ye, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093214 · Cited by 13
PML suppresses IL-6-induced STAT3 activation by interfering with STAT3 and HDAC3 interaction
Kato, M., Muromoto, R., Togi, S., Iwakami, M., Kitai, Y., Kon, S., Oritani, K., & Matsuda, T. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.04.040 · Cited by 13
Oka, M., Sumita, N., Sakaguchi, M., Iwasaki, T., Bito, T., Kageshita, T., Sato, K., Fukami, Y., & Nishigori, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.001073 · Cited by 13
Hilliard, T. S., Miklóssy, G., Chock, C., Yue, P., Williams, P. G., & Turkson, J. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0291 · Cited by 13
Murone, M., Radpour, R., Attinger, A., Chessex, A. V., Huguenin, A.-L., Schürch, C., Banz, Y., Sengupta, S., Aguet, M., Rigotti, S., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0889 · Cited by 13
A role for polycystin-1 and polycystin-2 in neural progenitor cell differentiation
Winokurow, N., & Schumacher, S. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03072-x · Cited by 13
The Dark Side of the Force: When the Immune System Is the Fuel of Tumor Onset
Digifico, E., Balinzo, S., & Belgiovine, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031224 · Cited by 15
Choi, C. H., Song, S. Y., Kang, H., Lee, Y.-Y., Kim, C., Lee, J., Kim, T., Kim, B., Lee, J., & Bae, D. (2010) · Journal of obstetrics and gynaecology research · doi:10.1111/j.1447-0756.2009.01131.x · Cited by 13
Montag, D. T., & Lotze, M. T. (2006) · Journal of Immunological Methods · doi:10.1016/j.jim.2006.03.014 · Cited by 13
Blank, V. C., Peña, C., & Roguin, L. P. (2009) · Experimental Cell Research · doi:10.1016/j.yexcr.2009.11.016 · Cited by 13
Zamanian, M. Y., Turkadze, K. A., Ivraghi, M. S., Golmohammadi, M., Sharifi, M., & Amlashi, Z. K. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70829 · Cited by 12
Ruff, K., Puetter, A., & Levy, L. S. (2007) · BMC Cancer · doi:10.1186/1471-2407-7-35 · Cited by 12
Kaymaz, B. T., Selvi, N., Saydam, G., Şahin, F., & Kosova, B. (2012) · Hematology · doi:10.1179/102453312x13221316477859 · Cited by 12
Lindner, A. U., Carberry, S., Monsefi, N., Barat, A., Salvucci, M., O’Byrne, R., Zanella, E. R., Cremona, M., Hennessy, B. T., Bertotti, A., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33226 · Cited by 12
Wang, Y., Tang, F., Hu, X., Zheng, C., Gong, T., Zhou, Y., Luo, Y., & Min, L. (2020) · IUBMB Life · doi:10.1002/iub.2349 · Cited by 12
Inhibition of STAT3 enhances UCP1 expression and mitochondrial function in brown adipocytes.
Song, L.-N., Cao, X., Ji, W.-Y., Zhao, L., Yang, W., Lu, M., & Yang, J.-K. (2022) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2022.175040 · Cited by 8
Zhang, Z., & Zhu, Q. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512494 · Cited by 13
Deng, D., Gu, Y., Yang, L., Xue, J., Wang, J., Ai, G., & Li, X. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s81754 · Cited by 12
SR16388: a steroidal antiangiogenic agent with potent inhibitory effect on tumor growth in vivo
Chao, W.-R., Amin, K., Shi, Y. H., Hobbs, P. D., Tanabe, M., Tanga, M. J., Jong, L., Collins, N., Peters, R. H., Laderoute, K. R., et al. (2010) · Angiogenesis · doi:10.1007/s10456-010-9191-z · Cited by 12
Wei, X., Cheng, X., Peng, Y., Zheng, R., Chai, J., & Jiang, S. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.06.003 · Cited by 12
Up-Regulation of CX3CL1 via STAT3 Contributes to SMIR-Induced Chronic Postsurgical Pain
Shen, Y., Li, D., Li, B., Peng, X., Zhang, Y., Jiang, Y.-S., Xu, Y., Chen, H., & Xiong, Y.-C. (2018) · Neurochemical Research · doi:10.1007/s11064-017-2449-8 · Cited by 12
Gammaherpesviruses of New World primates
Fleckenstein, B., & Ensser, A. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511545313.061 · Cited by 12
Metadata
- Authors
- Bromberg, J., & Darnell, J. E.
- Affiliations
- Rockefeller University (US)
- ORCID
- Bromberg, Jacqueline
- Venue
- Oncogene
- Published
- 2000-05-25
- Volume
- 19
- Issue
- 21
- Pages
- 2468-2473
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1977681992
- Cited by
- 1,201
- References
- 66
- Citations by year
- 2026: 10 · 2025: 22 · 2024: 21 · 2023: 24 · 2022: 37 · 2021: 40 · 2020: 46 · 2019: 41 · 2018: 42 · 2017: 51 · 2016: 46 · 2015: 49 · 2014: 59 · 2013: 67 · 2012: 56
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Keywords
- STAT proteins, transcriptional regulation, cytokine signaling, JAK kinases, tyrosine phosphorylation, STAT1, STAT3, STAT5, cell cycle progression, apoptosis, tumor suppressor, cell transformation, carcinogenesis, transcriptional coactivator
- MeSH terms
- Animals, Cell Division, Cell Transformation, Neoplastic, DNA-Binding Proteins, Gene Expression Regulation, Humans, Milk Proteins, Neoplasms, Structure-Activity Relationship, Transcription, Genetic, Trans-Activators, STAT1 Transcription Factor, STAT3 Transcription Factor, STAT5 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review